ENST00000367079.3:c.*283T>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000367079.3(PFKFB2):​c.*283T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.125 in 518,216 control chromosomes in the GnomAD database, including 4,286 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1089 hom., cov: 32)
Exomes 𝑓: 0.13 ( 3197 hom. )

Consequence

PFKFB2
ENST00000367079.3 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0550

Publications

15 publications found
Variant links:
Genes affected
PFKFB2 (HGNC:8873): (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2) The protein encoded by this gene is involved in both the synthesis and degradation of fructose-2,6-bisphosphate, a regulatory molecule that controls glycolysis in eukaryotes. The encoded protein has a 6-phosphofructo-2-kinase activity that catalyzes the synthesis of fructose-2,6-bisphosphate, and a fructose-2,6-biphosphatase activity that catalyzes the degradation of fructose-2,6-bisphosphate. This protein regulates fructose-2,6-bisphosphate levels in the heart, while a related enzyme encoded by a different gene regulates fructose-2,6-bisphosphate levels in the liver and muscle. This enzyme functions as a homodimer. Two transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000367079.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.153 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000367079.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PFKFB2
NM_001018053.2
c.*283T>A
3_prime_UTR
Exon 15 of 15NP_001018063.1O60825-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PFKFB2
ENST00000367079.3
TSL:1
c.*283T>A
3_prime_UTR
Exon 15 of 15ENSP00000356046.2O60825-2
PFKFB2
ENST00000906543.1
c.*373T>A
3_prime_UTR
Exon 16 of 16ENSP00000576602.1
PFKFB2
ENST00000906544.1
c.*361T>A
3_prime_UTR
Exon 16 of 16ENSP00000576603.1

Frequencies

GnomAD3 genomes
AF:
0.114
AC:
17336
AN:
152132
Hom.:
1087
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0591
Gnomad AMI
AF:
0.145
Gnomad AMR
AF:
0.158
Gnomad ASJ
AF:
0.117
Gnomad EAS
AF:
0.0899
Gnomad SAS
AF:
0.109
Gnomad FIN
AF:
0.131
Gnomad MID
AF:
0.161
Gnomad NFE
AF:
0.135
Gnomad OTH
AF:
0.140
GnomAD4 exome
AF:
0.129
AC:
47386
AN:
365966
Hom.:
3197
Cov.:
0
AF XY:
0.129
AC XY:
24772
AN XY:
192598
show subpopulations
African (AFR)
AF:
0.0572
AC:
609
AN:
10642
American (AMR)
AF:
0.146
AC:
2169
AN:
14900
Ashkenazi Jewish (ASJ)
AF:
0.127
AC:
1435
AN:
11278
East Asian (EAS)
AF:
0.117
AC:
2830
AN:
24156
South Asian (SAS)
AF:
0.109
AC:
4424
AN:
40404
European-Finnish (FIN)
AF:
0.136
AC:
3103
AN:
22876
Middle Eastern (MID)
AF:
0.160
AC:
259
AN:
1614
European-Non Finnish (NFE)
AF:
0.137
AC:
29872
AN:
218732
Other (OTH)
AF:
0.126
AC:
2685
AN:
21364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1896
3792
5688
7584
9480
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.114
AC:
17338
AN:
152250
Hom.:
1089
Cov.:
32
AF XY:
0.115
AC XY:
8550
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0590
AC:
2452
AN:
41560
American (AMR)
AF:
0.158
AC:
2415
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
407
AN:
3470
East Asian (EAS)
AF:
0.0902
AC:
467
AN:
5180
South Asian (SAS)
AF:
0.110
AC:
530
AN:
4824
European-Finnish (FIN)
AF:
0.131
AC:
1390
AN:
10598
Middle Eastern (MID)
AF:
0.163
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
0.135
AC:
9204
AN:
67996
Other (OTH)
AF:
0.138
AC:
293
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
763
1526
2288
3051
3814
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0640
Hom.:
65
Bravo
AF:
0.112
Asia WGS
AF:
0.0960
AC:
335
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
7.5
DANN
Benign
0.86
PhyloP100
0.055
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs17258746;
hg19: chr1-207252647;
COSMIC: COSV107459513;
COSMIC: COSV107459513;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.